NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

47 hedge funds and large institutions have $36.6M invested in NeuBase Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 12 increasing their positions, 17 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$147K
Puts
$119K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$9.84M
2
$4.93M
3
$4.51M
4
$3.27M
5
$2.29M
6
$1.47M
7
$1.41M
8
$1.27M
9
$1.12M
10
$865K
11
$646K
12
$396K
13
$378K
14
$361K
15
$315K
16
$310K
17
$295K
18
$271K
19
$269K
20
$267K
21
$230K
22
$218K
23
$211K
24
$209K
25
$198K